Page last updated: 2024-11-05

thalidomide and Celiac Sprue

thalidomide has been researched along with Celiac Sprue in 2 studies

Thalidomide: A piperidinyl isoindole originally introduced as a non-barbiturate hypnotic, but withdrawn from the market due to teratogenic effects. It has been reintroduced and used for a number of immunological and inflammatory disorders. Thalidomide displays immunosuppressive and anti-angiogenic activity. It inhibits release of TUMOR NECROSIS FACTOR-ALPHA from monocytes, and modulates other cytokine action.
thalidomide : A racemate comprising equimolar amounts of R- and S-thalidomide.
2-(2,6-dioxopiperidin-3-yl)-1H-isoindole-1,3(2H)-dione : A dicarboximide that is isoindole-1,3(2H)-dione in which the hydrogen attached to the nitrogen is substituted by a 2,6-dioxopiperidin-3-yl group.

Research Excerpts

ExcerptRelevanceReference
"Although peripheral neuropathies in children are often of genetic origin, acquired causes should be carefully looked for and ruled out also in the pediatric age."2.58Peripheral neuropathy and gastroenterologic disorders: an overview on an underrecognized association. ( De' Angelis, GL; Di Mario, F; Fusco, C; Gaiani, F; Leandro, G; Pisani, F; Spagnoli, C, 2018)

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (50.00)18.2507
2000's0 (0.00)29.6817
2010's1 (50.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Spagnoli, C1
Pisani, F1
Di Mario, F1
Leandro, G1
Gaiani, F1
De' Angelis, GL1
Fusco, C1
MacPhail, L1

Reviews

2 reviews available for thalidomide and Celiac Sprue

ArticleYear
Peripheral neuropathy and gastroenterologic disorders: an overview on an underrecognized association.
    Acta bio-medica : Atenei Parmensis, 2018, 12-17, Volume: 89, Issue:9-S

    Topics: Antibodies, Monoclonal; Antirheumatic Agents; Campylobacter Infections; Celiac Disease; Child; Comor

2018
Topical and systemic therapy for recurrent aphthous stomatitis.
    Seminars in cutaneous medicine and surgery, 1997, Volume: 16, Issue:4

    Topics: Adjuvants, Immunologic; Administration, Topical; Adrenal Cortex Hormones; Analgesics; Anti-Inflammat

1997